In 2023, Germany led global hospital discharges for endocrine, nutritional, and metabolic diseases with a value of 572.81k, followed by the UK and Australia. The UK saw the highest year-on-year increase at 1.86%, while Canada experienced a decline at -1.19%. Over five years, trends indicate stable or slight increases in most countries, though some like Norway showed negative growth.
Looking ahead, expect increased discharges driven by aging populations and rising incidence of metabolic disorders. Innovations in treatment and preventive healthcare strategies may impact future volumes. Close monitoring of demographic and healthcare infrastructure changes will be key in forecasting accurately.
Top countries in Hospital Discharges for Endocrine, Nutritional and Metabolic Diseases Cases by Country
| # | 9 Countries | Units (Hospital Discharges) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 572,810 | 2023 | +4.02% | +0.17% | View data |
| 2 | 2 United Kingdom | 193,370 | 2023 | +1.9% | +1.86% | View data |
| 3 | 3 Australia | 129,510 | 2023 | +1.47% | +1.77% | View data |
| 4 | 4 Spain | 90,120 | 2023 | +4% | +0.47% | View data |
| 5 | 5 Canada | 79,390 | 2023 | +0.43% | -1.19% | View data |
| 6 | 6 Austria | 55,410 | 2023 | +4.57% | +0.08% | View data |
| 7 | 7 Slovakia | 25,720 | 2023 | +4.22% | -0.85% | View data |
| 8 | 8 Portugal | 20,310 | 2021 | +14.91% | View data | |
| 9 | 9 Norway | 16,440 | 2023 | -0.59% | -1.56% | View data |
